Growth & development


At Salin, M2i is investing in and drawing on its teams to ensure performance for the benefit of its clients. Our team, which consisted of 36 persons at the start of 2013, now counts 56 colleagues who receive annual training in order to allow the site to meet ever-increasing market and regulatory requirements.

Every year, M2i Salin initiates new development projects which allow it to expand its know-how and offer new opportunities to its clients.



M2i Salin is continually implicated in upgrading its installations in order to guarantee that its industrial facilities are maintained at the standards necessary for the production of pharmaceutical active ingredients. These investments cover all site activities, from R&D to production via analytical control.

In order to support the steady growth of production and business diversification, especially industrialising 20 new benchmarks, the Salin-de-Giraud site—which was previously 2x8—is currently (since 1 January 2014) operating 3x8. This allows round-the-clock attention to sensitive operating systems and considerably increases our responsiveness and site production capacity.